Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

CEFAZOLIN IN DEXTROSE

CEFAZOLIN SODIUM

Standard Dose
EQ 2GM BASE/100ML (EQ 20MG BASE/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview CEFAZOLIN IN DEXTROSE is listed in Drugs@FDA under application 207131 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient CEFAZOLIN SODIUM Form and strength SOLUTION;INTRAVENOUS - EQ 2GM BASE/100ML (EQ 20MG BASE/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2024-05-31 00:00:00.

Structured Monograph

Clinical summary

Approval overview CEFAZOLIN IN DEXTROSE is listed in Drugs@FDA under application 207131 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CEFAZOLIN SODIUM Form and strength SOLUTION;INTRAVENOUS - EQ 2GM BASE/100ML (EQ 20MG BASE/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2024-05-31 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.